How much does Adcetris (Brentuximab Vedotin for Injection) Cost& price without insurance in China?
Adcetris® is the commercial brand name of Brentuximab Vedotin for Injection, an antibody-drug conjugate developed by Seagen. It binds to CD30 antigen on malignant lymphoma cells and releases cytotoxic agent inside tumor cells to induce cell apoptosis.
Main Indications
Treatment of relapsed/refractory CD30-positive classical Hodgkin lymphoma;
Treatment of relapsed/refractory systemic anaplastic large cell lymphoma.
Common Side Effects
Common mild adverse reactions: Peripheral neuropathy, fatigue, nausea, diarrhea and neutropenia.
Laboratory abnormalities: Decreased blood cell counts and transient hepatic enzyme elevation.
Severe but manageable risks: Progressive multifocal leukoencephalopathy, severe infusion hypersensitivity and severe myelosuppression.
Approval Status in China
Adcetris® (Brentuximab Vedotin for Injection, 50mg per vial) was officially approved for marketing in China in 2020. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Adcetris (Brentuximab Vedotin for Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
